FDA and NIH postpone Rare Disease Day event, raising concerns
The US Food and Drug Administration (FDA) and the National Institutes of Health (NIH) have postponed the annual Rare Disease Day event, originally set for February 27-28. As reported by Reuters, this is the second health meeting delayed since Robert F Kennedy Jr became HHS Secretary. Advocates expressed concern, citing agency layoffs. The FDA plans to reschedule the event in the coming months.